Möchten Sie immer auf dem neuesten Stand bleiben?

Dublin, Feb. 21, 2020 (GLOBE NEWSWIRE) -- The "Medical Sensors Market by Sensors Type (Pressure, Temperature, Blood Oxygen, Blood Glucose, Ingestible), Application (Monitoring, Diagnostic...

SPARTA, N.J., Feb. 21, 2020 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on developing more effective and safer...

Results from mTNBC and MBC studies continues to be positive with the first patient now at almost five months of treatment showing zero CTC, EMT and CAML. Seven patients have been enrolled to date ...

Dublin, Feb. 21, 2020 (GLOBE NEWSWIRE) -- The "Preparing for FDA's New Import/Export Trauma in 2020" conference has been added to ResearchAndMarkets.com's offering. The FDA continues...

REGULATED INFORMATION Ghent, BELGIUM – 21 February 2020 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), an innovator in the management of fluid overload in...

HIGH POINT, N.C., Feb. 20, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the fourth quarter and year ended December 31, 2019, and provided an...

SANTA BARBARA, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, announced today that members of management are scheduled to present at the 9th...

GENFIT : levée d’aveugle des données de la Phase 3 RESOLVE-IT différée Lille (France), Cambridge (Massachusetts, États-Unis), le 20 février 2020 – GENFIT (Euronext : GNFT - ISIN : FR0004163111),...

CORRECTION GENFIT: Unblinding of Phase 3 RESOLVE-IT Data Deferred This release is being issued to correctly state that the Phase 3 RESOLVE-IT trial remains blinded. This release replaces the...

NEW YORK and LONDON, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and...

NEW YORK, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central...

NEW YORK, Feb. 20, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that...

GAITHERSBURG, Md., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) reported financial results for the quarter and year ended December 31, 2019. FINANCIAL HIGHLIGHTS (in...

ANJESO Is The Only Approved 24-Hour, Intravenous COX-2 Preferential NSAID that Offers Once-Daily Dosing U.S. Commercial Launch Planned to Commence in Late April or Early May 2020 Management to Host...

Total Revenue Increases 10% Year-over-Year for the Fourth QuarterCompletes Acquisitions of Parcus Medical and ArthrosurfaceCompany Expects Total Revenue Growth in the 40% to 44% Range for Full Year...

SUNNYVALE, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Simplify Medical Pty Ltd, maker of the Simplify® cervical artificial disc, announced today the International Society for the Advancement of Spine...

MENLO PARK, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe...

Presented positive clinical and pre-clinical data from its MarzAA and DalcA hemophilia programs Announced a global license and collaboration agreement with Biogen to develop and commercialize...

Current Cash and Cash Equivalents Expected to Meet Projected Operating Requirements through End of 2020 Twirla®, Company’s Lead Product Candidate, Receives FDA Approval Company Plans to Commence...

EMERYVILLE, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a clinically meaningful...

STAMFORD, Conn., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...

VANCOUVER, Washington, Feb. 20, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5...

New York, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Migraine Therapeutics Market - Growth, Trends, and Forecast (2020 - 2025)" -...

WASHINGTON, Feb. 20, 2020 (GLOBE NEWSWIRE) -- DirectTrust is pleased to announce Konica Minolta Business Solutions, U.S.A., Inc. (Konica Minolta) as Platinum Sponsor and Health Catalyst, Harmony...

NEW YORK, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest from leaders at Disney (DIS), Spotify (SPOT)...

MIAMI, Feb. 20, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended December 31, 2019, as well as provide guidance on...

New York, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Allergy Immunotherapy Market - Growth, Trends, and Forecast (2019 - 2024)" -...

Los Angeles, CA, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced undertaking initial steps for obtaining medical...

BOSTON and DURHAM, N.C. and BRISBANE, Australia , Feb. 20, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to...

New York, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Inulin Market - Analysis Of Growth, Trends, And Forecast (2019 - 2024)" -...

WEST CHESTER, Pa., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for viral skin diseases...

Revenue increases by 64% to EUR 2.3 million, up from 1.4 million in 2018 More than tripled total contract order volume received year-over-year to about EUR 3.4 million 2019 Combined revenue for...

Lucid secures exclusive option to license biomarker technology to detect progression from nondysplastic to dysplastic BE using EsoCheck to allow curative ablation before deadly esophageal cancer...

NEW YORK and SYDNEY, Australia, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused...

SOUTH JORDAN, Utah, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology,...

New York, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Neurodegenerative Disease Market - Growth, Trends, and Forecast (2019 - 2024)" -...

WESTLAKE VILLAGE, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced the presentation of results from multiple clinical studies of Afrezza® (insulin human)...

TAMPA, Fla., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Solace Behavioral Health, a mental health clinic offering advanced treatments for mental health disorders, announced today that it will host an grand...

NEW YORK, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...

AUSTIN, Texas, Feb. 20, 2020 (GLOBE NEWSWIRE) -- The American Botanical Council (ABC) announces that the 2019 Varro E. Tyler Commercial Investment in Phytomedicinal Research Award will be presented...

DEVON, Pa., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare...

Provides funds to evaluate the mechanistic antiviral activity of WH602Novan to progress IND-enabling toxicology and pharmacology studies for WH602 Grant is additive to $223,000 Phase 1 NIH grant...

SAN DIEGO, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...

ORLANDO, Fla., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Earlier this week, the medical diagnostic and healthcare tech company opened its fourth quarter earnings book covering the three-month period ending...

MORRIS PLAINS, N.J., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug...

SUWANEE, GA, Feb. 20, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) – is pleased and proud to announce their participation and world-wide launch of dermaPACE® at...

A first of its kind synthetic cannabinoid medication to manage eye pain in the veterinary setting Trial expected to be completed by April 30, 2020 OTTAWA, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Tetra...

— Full-year 2019 revenue increases 25 percent to $421 million versus 2018 —— Total 2020 revenue guidance of between $485 million and $500 million —— Anesthesia-driven regional approaches are expanding...

SCOTTSDALE, Ariz., Feb. 20, 2020 (GLOBE NEWSWIRE) -- The Alkaline Water Company Inc. (NASDAQ and TSXV: WTER) (the “Company”), a producer of premium bottled alkaline and flavored water sold under the...

This clinical trial will investigate for the first time a combination of VB-111 with a checkpoint inhibitor.Pathology readouts are expected to shed light on the potential of VB-111 to turn “cold”...